Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 72162-2516

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72162-2516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Divalproex Fig1)

Figure 1 (Divalproex Fig1)
This is a comparison of the reduction in the CPS rate between Divalproex Sodium Delayed-Release Tablets and Placebo. The figure shows the percentage of patients with improvement, no change, and worsening in the CPS rate.*
FDA Label Image

Figure 2 (Divalproex Fig2)

Figure 2 (Divalproex Fig2)
This text describes a figure showing the percentage reduction in CPS rate associated with High Dose and Low Dose Divalproex Sodium Delayed-Release Tablets. The figure depicts the percentage of patients experiencing improvement, no change, or worsening in CPS rate after using the medication.*
FDA Label Image

Figure-3 (Divalproex Fig3)

Figure-3 (Divalproex Fig3)
This text contains information regarding measurements and a medication called Divalproex Sodium Extended-Release Tablets. The text also includes mathematical expressions.*
FDA Label Image

Structure (Divalproex Str)

FDA Label Image

Label (Lbl721622516)

Label (Lbl721622516)
This is a description of an extended-release tablet containing Divalproex Sodium USP equivalent to valproic acid 500mg. It provides instructions for daily dosing, usual dosage, storage conditions, and precautions like keeping the medication out of reach of children and protecting it from light. The tablets come in a package with a QR code to access prescribing information and a Medication Guide. The tablets are manufactured by Aurobindo Pharma Limited and should be dispensed in a USP tight, light-resistant container. It also advises not to accept the tablets if the seal over the bottle opening is broken or missing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.